Drug eluting ocular implant
US12201555B2 · kind B2 · utility
3Cited by
323References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 31, 2021 |
| Grant date | Jan 21, 2025 |
| Priority date | — |
| Expiry date | Dec 28, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61F2250/0068
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allows for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.